Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 721 to 735 of 811 results for adult social

  1. Tools for case identification for cognitive impairment in criminal justice system populations:- What are the reliable and valid tools to identify cognitive impairment among people in contact with the criminal justice system (including people who have experienced physical trauma, neurodevelopmental disorders or other acquired cognitive impairment)?

    common in criminal justice system populations and may be associated with poor social, occupational an interpersonal functioning. Also,...

    Research recommendation
    Published
    16 May 2017

  2. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of children at high risk of poor oral health?

    outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  3. Is an integrated care system effective at promoting successful progress for people with complex psychosis to a more independent setting?

    system to support transitions. The integrated system was a team of health and social care practitioners and informal carers for each...

    Research recommendation
    Published
    26 October 2020

  4. QuikRead go for C-reactive protein testing in primary care (MIB78)

    NICE has developed a medtech innovation briefing (MIB) on the QuikRead go for C-reactive protein testing in primary care

    Medtech innovation briefing
    Published
    14 September 2016

  5. Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis (MIB93)

    NICE has developed a medtech innovation briefing (MIB) on the Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis .

    Medtech innovation briefing
    Published
    18 January 2017

  6. Managing glioma: supportive care clinics for low-grade glioma:- Does a dedicated supportive care clinic in addition to standard care improve outcomes for people with low-grade gliomas?

    complex healthcare needs across multiple physical, cognitive, emotional and social domains. This is often from the initial diagnosis...

    Research recommendation
    Published
    11 December 2018

  7. What is the comparative effectiveness and cost effectiveness of exercise referral schemes compared with other interventions that aim to help people to become more physically active? Relative effectiveness and cost effectiveness should be compared in controlled trials.

    referral schemes that seek to improve the health of sedentary or inactive adults with an existing health condition – or other factors...

    Research recommendation
    Published
    9 June 2015

  8. What factors encourage uptake of, and adherence to, an exercise referral scheme? Factors to consider include: design, content and delivery; referral mechanisms; choice of activity; qualifications and cost of instructors. Also identify any barriers preventing participation and factors that encourage it.

    referral schemes that seek to improve the health of sedentary or inactive adults with an existing health condition – or other factors...

    Research recommendation
    Published
    9 June 2015

  9. What factors encourage under-represented groups to participate in and complete an exercise referral scheme? What factors prevent these groups from participating? Under-represented groups include: people from black and minority ethnic groups, people with disabilities and those from lower socioeconomic groups.

    referral schemes that seek to improve the health of sedentary or inactive adults with an existing health condition – or other factors...

    Research recommendation
    Published
    9 June 2015

  10. Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can tools be developed and/or existing ones further refined and validated to: - assess disease severity and impact in both non-specialist and specialist healthcare settings, to facilitate assessment, appropriate referral, treatment planning and measurement of outcomes - measure burden and cumulative effect of disease activity, severity and impact for people with both psoriasis and psoriatic arthritis?

    Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can tools be developed and/or existing...

    Research recommendation
    Published
    9 June 2015

  11. Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic assessment and intervention for people living with high levels of multimorbidity?

    However, the studies were conducted outside the UK and were not aimed at all adults living with multimorbidity. The guideline committee...

    Research recommendation
    Published
    18 October 2016

  12. Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer (TA741)

    Evidence-based recommendations on apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer in adults.

    Technology appraisal guidance
    Published
    28 October 2021
    View recommendations

    Sections for TA741

  13. Empagliflozin in combination therapy for treating type 2 diabetes (TA336)

    Evidence-based recommendations on empagliflozin (Jardiance) in combination therapy for treating type 2 diabetes.

    Technology appraisal guidance
    Published
    25 March 2015
    View recommendations

    Sections for TA336

  14. Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (TA687)

    Evidence-based recommendations on ribociclib (Kisqali) for treating hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in adults who have had previous endocrine therapy.

    Technology appraisal guidance
    Published
    31 March 2021
    View recommendations

    Sections for TA687

  15. Nivolumab for previously treated advanced renal cell carcinoma (TA417)

    Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma in adults.

    Technology appraisal guidance
    Published
    23 November 2016
    View recommendations

    Sections for TA417